NeuraCeq® (Florbetaben F-18 injection)

NeuraCeq® (Florbetaben F-18 injection) is a radiopharmaceutical indicated for Positron Emission Tomography (PET) imaging of β-amyloid neuritic plaque density in the brains of adult patients with cognitive impairment who are being evaluated for Alzheimer’s disease (AD) and other causes of cognitive impairment.

  • AVAILABILITY: Every Monday and Tuesday
  • CALIBRATION: 12:00 pm, CET same day
  • PACKAGING: 15 ml multi-dose colorless glass vial – Type I
  • ORDERING: Curium Pharma is the exclusive distributor for NeuraCeq® (Florbetaben F-18 injection) of BV Cyclotron VU